Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
February 28, 2009
Biochemical basis for differences in metabolism-dependent genotoxicity by two diazinylpiperazine-based 5-HT2C receptor agonists
Amit S Kalgutkar, Jonathan N Bauman, Kim F McClure, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 17, 2002
The effect of bergamottin on diazepam plasma levels and P450 enzymes in beagle dogs
Jasminder Sahi, Eric L Reyner, Jonathan N Bauman, et al.
Clinical Immunology and Immunopathology
|
December 1, 1984
Passive transfer of collagen arthritis: studies with affinity-purified anticollagen IgG prepared in rabbits
S C Ridge, R A McReynolds, Y L Mitcho, et al.
The Journal of Arthroplasty
|
July 6, 2024
The Impact of Diagnosed Chronic Sleep Disorders on Outcomes Following Total Knee Arthroplasty
Fehmi B Berkay, Rodney W Benner, Scot N Bauman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 24, 2014
Biosynthesis of drug metabolites and quantitation using NMR spectroscopy for use in pharmacologic and drug metabolism studies
Gregory S Walker, Jonathan N Bauman, Tim F Ryder, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 2, 2007
Atorvastatin glucuronidation is minimally and nonselectively inhibited by the fibrates gemfibrozil, fenofibrate, and fenofibric acid
Theunis C Goosen, Jonathan N Bauman, John A Davis, et al.
Chemical Research in Toxicology
|
January 24, 2009
Can in vitro metabolism-dependent covalent binding data distinguish hepatotoxic from nonhepatotoxic drugs? An analysis using human hepatocytes and liver S-9 fraction
Jonathon N Bauman, Joan M Kelly, Sakambari Tripathy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 12, 2008
Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug
Jonathan N Bauman, Kosea S Frederick, Aarti Sawant, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 30, 2026
Human absorption, distribution, metabolism, excretion, and reaction phenotyping of ervogastat (PF-06865571), a diacylglycerol O-acyltransferase 2 inhibitor
Manoli Vourvahis, Christine C Orozco, David Tess, et al.
The International Journal of Eating Disorders
|
January 1, 1995
Indirect calorimetry in the nutritional management of eating disorders
J Schebendach, N H Golden, M S Jacobson, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
Bioorganic & Medicinal Chemistry Letters
|
February 28, 2009
Biochemical basis for differences in metabolism-dependent genotoxicity by two diazinylpiperazine-based 5-HT2C receptor agonists
Amit S Kalgutkar, Jonathan N Bauman, Kim F McClure, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 17, 2002
The effect of bergamottin on diazepam plasma levels and P450 enzymes in beagle dogs
Jasminder Sahi, Eric L Reyner, Jonathan N Bauman, et al.
Clinical Immunology and Immunopathology
|
December 1, 1984
Passive transfer of collagen arthritis: studies with affinity-purified anticollagen IgG prepared in rabbits
S C Ridge, R A McReynolds, Y L Mitcho, et al.
The Journal of Arthroplasty
|
July 6, 2024
The Impact of Diagnosed Chronic Sleep Disorders on Outcomes Following Total Knee Arthroplasty
Fehmi B Berkay, Rodney W Benner, Scot N Bauman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 24, 2014
Biosynthesis of drug metabolites and quantitation using NMR spectroscopy for use in pharmacologic and drug metabolism studies
Gregory S Walker, Jonathan N Bauman, Tim F Ryder, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
May 2, 2007
Atorvastatin glucuronidation is minimally and nonselectively inhibited by the fibrates gemfibrozil, fenofibrate, and fenofibric acid
Theunis C Goosen, Jonathan N Bauman, John A Davis, et al.
Chemical Research in Toxicology
|
January 24, 2009
Can in vitro metabolism-dependent covalent binding data distinguish hepatotoxic from nonhepatotoxic drugs? An analysis using human hepatocytes and liver S-9 fraction
Jonathon N Bauman, Joan M Kelly, Sakambari Tripathy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 12, 2008
Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug
Jonathan N Bauman, Kosea S Frederick, Aarti Sawant, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
April 30, 2026
Human absorption, distribution, metabolism, excretion, and reaction phenotyping of ervogastat (PF-06865571), a diacylglycerol O-acyltransferase 2 inhibitor
Manoli Vourvahis, Christine C Orozco, David Tess, et al.
The International Journal of Eating Disorders
|
January 1, 1995
Indirect calorimetry in the nutritional management of eating disorders
J Schebendach, N H Golden, M S Jacobson, et al.
Page
of 6